Masahiko Watanabe

2.6k total citations
78 papers, 1.9k citations indexed

About

Masahiko Watanabe is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Masahiko Watanabe has authored 78 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 26 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Masahiko Watanabe's work include Gastric Cancer Management and Outcomes (21 papers), Colorectal Cancer Treatments and Studies (14 papers) and Gastrointestinal Tumor Research and Treatment (9 papers). Masahiko Watanabe is often cited by papers focused on Gastric Cancer Management and Outcomes (21 papers), Colorectal Cancer Treatments and Studies (14 papers) and Gastrointestinal Tumor Research and Treatment (9 papers). Masahiko Watanabe collaborates with scholars based in Japan, United States and United Kingdom. Masahiko Watanabe's co-authors include Hiroshi Katoh, Keishi Yamashita, Masaru Kuranami, Christopher W. Knouff, Patrick M. Sullivan, Nobuyo Maeda, Michael K. Altenburg, Myron E. Hinsdale, Steven H. Quarfordt and Reiko Woodhams and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Masahiko Watanabe

75 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masahiko Watanabe Japan 22 716 450 382 346 328 78 1.9k
Diana Lüftner Germany 27 1.4k 1.9× 547 1.2× 523 1.4× 254 0.7× 489 1.5× 176 2.4k
James T. Thackeray Germany 25 403 0.6× 393 0.9× 282 0.7× 362 1.0× 831 2.5× 83 2.0k
Shuichi Mitsunaga Japan 28 1.0k 1.5× 544 1.2× 347 0.9× 473 1.4× 193 0.6× 125 2.5k
Yukihiro Yoshida Japan 26 654 0.9× 666 1.5× 961 2.5× 315 0.9× 239 0.7× 148 2.5k
Andrea Remo Italy 26 754 1.1× 586 1.3× 299 0.8× 240 0.7× 133 0.4× 76 1.7k
G Gardani Italy 20 660 0.9× 233 0.5× 499 1.3× 495 1.4× 286 0.9× 67 1.7k
Jennifer M. Johnson United States 25 847 1.2× 612 1.4× 364 1.0× 473 1.4× 83 0.3× 104 2.3k
Luka Brčić Austria 31 606 0.8× 563 1.3× 882 2.3× 655 1.9× 132 0.4× 143 2.5k
Takashi Ohigashi Japan 25 463 0.6× 547 1.2× 926 2.4× 395 1.1× 162 0.5× 94 2.1k
Dimitrios C. Ziogas Greece 26 913 1.3× 755 1.7× 217 0.6× 249 0.7× 98 0.3× 99 2.2k

Countries citing papers authored by Masahiko Watanabe

Since Specialization
Citations

This map shows the geographic impact of Masahiko Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiko Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiko Watanabe more than expected).

Fields of papers citing papers by Masahiko Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiko Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiko Watanabe. The network helps show where Masahiko Watanabe may publish in the future.

Co-authorship network of co-authors of Masahiko Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiko Watanabe. A scholar is included among the top collaborators of Masahiko Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiko Watanabe. Masahiko Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yamaguchi, Tomohiro, Keitaro Tanaka, Jun Watanabe, et al.. (2025). Short‐term outcomes of intracorporeal anastomosis in laparoscopic colectomy for colon cancer: A nationwide, multi‐institutional cohort study in Japan (ICAN study). Annals of Gastroenterological Surgery. 9(4). 739–749.
3.
Kondo, Yasushi, Takashi Fukuyama, Nobue Futawatari, et al.. (2018). Detection of KK-LC-1 Protein, a Cancer/Testis Antigen, in Patients with Breast Cancer. Anticancer Research. 38(10). 5923–5928. 18 indexed citations
4.
Matsuda, Chu, Megumi Ishiguro, Satoshi Teramukai, et al.. (2018). A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur–uracil versus surgery alone in stage II colon cancer: SACURA trial. European Journal of Cancer. 96. 54–63. 50 indexed citations
5.
Terashima, Masanori, Kazuhiro Yoshida, Sun Young Rha, et al.. (2018). International retrospective cohort study of conversion therapy for stage IV gastric cancer 1 (CONVO-GC-1).. Journal of Clinical Oncology. 36(15_suppl). 4042–4042. 7 indexed citations
6.
Kumamoto, Yusuke, Takashi Kaizu, Hiroshi Tajima, et al.. (2018). Neutrophil‑to‑lymphocyte ratio as a predictor of postoperative morbidity in patients with distal cholangiocarcinoma. Molecular and Clinical Oncology. 9(4). 362–368. 28 indexed citations
7.
8.
Nakamura, Kazunori, Keishi Yamashita, Hiromichi Sawaki, et al.. (2015). Aberrant methylation of GCNT2 is tightly related to lymph node metastasis of primary CRC.. PubMed. 35(3). 1411–21. 22 indexed citations
9.
Hosoda, Kei, et al.. (2015). Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction. General Thoracic and Cardiovascular Surgery. 63(10). 549–556. 13 indexed citations
10.
Nishimiya, Hiroshi, Yoshimasa Kosaka, Keishi Yamashita, et al.. (2014). Prognostic significance of Ki-67 in chemotherapy-naive breast cancer patients with 10-year follow-up.. PubMed. 34(1). 259–68. 13 indexed citations
11.
Ema, Akira, Mina Waraya, Keishi Yamashita, et al.. (2014). Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer. Cancer Medicine. 4(1). 90–100. 24 indexed citations
12.
Yasui, Hirofumi, Kei Muro, Yasuhiro Shimada, et al.. (2014). A phase 3 non-inferiority study of 5-FU/l-leucovorin/irinotecan (FOLFIRI) versus irinotecan/S-1 (IRIS) as second-line chemotherapy for metastatic colorectal cancer: updated results of the FIRIS study. Journal of Cancer Research and Clinical Oncology. 141(1). 153–160. 19 indexed citations
13.
Ooki, Akira, Keishi Yamashita, Kensei Yamaguchi, et al.. (2013). DNA Damage-Inducible Gene, Reprimo Functions as a Tumor Suppressor and Is Suppressed by Promoter Methylation in Gastric Cancer. Molecular Cancer Research. 11(11). 1362–1374. 35 indexed citations
14.
Takahari, Daisuke, Yasuhide Yamada, Hiroshi Matsumoto, et al.. (2013). A randomized phase III trial of S-1/oxaliplatin (SOX) plus bevacizumab versus 5-FU/l-LV/oxaliplatin (mFOLFOX6) plus bevacizmab in patients with metastatic colorectal cancer: The SOFT study.. Journal of Clinical Oncology. 31(15_suppl). 3519–3519. 2 indexed citations
15.
Nakamoto, Yoshihiko, Megumi Ishiguro, Motoki Yoshida, et al.. (2013). Noninferiority of S-1 to UFT/LV as adjuvant chemotherapy for stage III colon cancer: A randomized phase III trial (ACTS-CC).. Journal of Clinical Oncology. 31(15_suppl). 3518–3518. 6 indexed citations
16.
Kosaka, Yoshimasa, Akemi Kataoka, Hiroshi Yamaguchi, et al.. (2012). Vascular endothelial growth factor receptor-1 mRNA overexpression in peripheral blood as a useful prognostic marker in breast cancer. Breast Cancer Research. 14(5). R140–R140. 7 indexed citations
17.
Hosono, Kanako, Tatsunori Suzuki, Yasufumi Ogawa, et al.. (2009). Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis. Biomedicine & Pharmacotherapy. 64(2). 101–106. 34 indexed citations
18.
Saikawa, Yoshiro, Tetsuro Kubota, Tsong‐Hong Kuo, et al.. (1993). Enhancement of Antitumor Activity of Cisplatin on Human Gastric Cancer Cells in vitro and in vivo by Buthionine Sulfoximine. Japanese Journal of Cancer Research. 84(7). 787–793. 9 indexed citations
19.
Uno, Masashi, Hajime Tsuji, Masahiko Watanabe, et al.. (1989). Application of thrombin-antithrombin III complex for detecting a latent hypercoagulable state in patients with coronary artery disease.. Japanese Circulation Journal. 53(10). 1185–1191. 8 indexed citations
20.
Yamada, Tesshi, et al.. (1987). Monoclonal Antibody Raised by Sera of Athymic Mice Bearing Human Lung Cancer Xenografts. Oncology. 44(3). 186–191. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diana Lüftner Breakdown of academic impact, for papers by James T. Thackeray Breakdown of academic impact, for papers by Shuichi Mitsunaga Breakdown of academic impact, for papers by Yukihiro Yoshida Breakdown of academic impact, for papers by Andrea Remo Breakdown of academic impact, for papers by G Gardani Breakdown of academic impact, for papers by Jennifer M. Johnson Breakdown of academic impact, for papers by Luka Brčić Breakdown of academic impact, for papers by Takashi Ohigashi Breakdown of academic impact, for papers by Dimitrios C. Ziogas
Rankless by CCL
2026